Cabot Corporation (NYSE:CBT) Receives Consensus Recommendation of “Reduce” from Brokerages

Cabot Corporation (NYSE:CBT) has earned a consensus rating of “Reduce” from the five analysts that are presently covering the firm, MarketBeat reports. Two research analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation and one has issued a buy recommendation on the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $66.3333.

Several equities analysts have recently commented on CBT shares. Weiss Ratings reiterated a “hold (c-)” rating on shares of Cabot in a research report on Monday. JPMorgan Chase & Co. cut their target price on Cabot from $75.00 to $54.00 and set an “underweight” rating for the company in a research note on Friday, November 28th. UBS Group reduced their price target on shares of Cabot from $82.00 to $65.00 and set a “neutral” rating on the stock in a research report on Wednesday, November 5th. Mizuho boosted their price objective on shares of Cabot from $72.00 to $80.00 and gave the stock an “outperform” rating in a report on Thursday, December 18th. Finally, Zacks Research cut shares of Cabot from a “hold” rating to a “strong sell” rating in a research note on Friday, November 7th.

Cabot Stock Performance

NYSE CBT opened at $66.45 on Wednesday. Cabot has a 52-week low of $58.33 and a 52-week high of $92.89. The company has a fifty day moving average of $64.99 and a 200-day moving average of $72.51. The company has a market capitalization of $3.52 billion, a P/E ratio of 11.06, a P/E/G ratio of 3.46 and a beta of 0.90. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.08 and a current ratio of 1.61.

Cabot (NYSE:CBT) last released its earnings results on Monday, November 3rd. The specialty chemicals company reported $1.70 EPS for the quarter, missing analysts’ consensus estimates of $1.72 by ($0.02). Cabot had a net margin of 8.91% and a return on equity of 24.55%. The firm had revenue of $899.00 million during the quarter, compared to the consensus estimate of $967.02 million. During the same period in the prior year, the company earned $1.80 EPS. The firm’s revenue was down 10.2% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.000-7.00 EPS. As a group, equities research analysts predict that Cabot will post 7.57 EPS for the current fiscal year.

Cabot Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 12th. Stockholders of record on Friday, November 28th were paid a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date of this dividend was Friday, November 28th. Cabot’s dividend payout ratio (DPR) is 29.95%.

Hedge Funds Weigh In On Cabot

Several institutional investors and hedge funds have recently bought and sold shares of CBT. Norges Bank bought a new stake in Cabot in the second quarter valued at approximately $51,710,000. AQR Capital Management LLC increased its stake in shares of Cabot by 123.0% in the second quarter. AQR Capital Management LLC now owns 867,946 shares of the specialty chemicals company’s stock worth $65,096,000 after buying an additional 478,702 shares during the period. UBS Group AG raised its holdings in Cabot by 186.7% during the 3rd quarter. UBS Group AG now owns 593,510 shares of the specialty chemicals company’s stock valued at $45,136,000 after buying an additional 386,514 shares during the last quarter. American Century Companies Inc. raised its holdings in Cabot by 11.1% during the 2nd quarter. American Century Companies Inc. now owns 1,664,728 shares of the specialty chemicals company’s stock valued at $124,855,000 after buying an additional 166,460 shares during the last quarter. Finally, Goldman Sachs Group Inc. boosted its position in Cabot by 32.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 442,646 shares of the specialty chemicals company’s stock valued at $36,802,000 after buying an additional 108,645 shares during the period. 93.18% of the stock is currently owned by institutional investors.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.